Geoffrey Martha - 04 Jun 2026 Form 4 Insider Report for Medtronic plc (MDT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Jun 2026, 17:03:17 UTC
Prior SEC filing
28 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Patricia Walesiewicz, attorney-in-fact

Key filing fact

Geoffrey Martha filed Form 4 for Medtronic plc (MDT) on 08 Jun 2026.

Key facts

  • This page summarizes Geoffrey Martha's Form 4 filing for Medtronic plc (MDT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Jun 2026, 17:03.

Change

  • Previous filing in this sequence was filed on 28 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001560409 Primary reporting owner

Martha Geoffrey

Relationship
Chairman and CEO, Director
Address
710 MEDTRONIC PARKWAY, MINNEAPOLIS
Signature
/s/ Patricia Walesiewicz, attorney-in-fact
Signature date
08 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Tax liability

Transaction value
Shares
-41,936
Change %
-12%
Price
$83.32*
Shares after
301,163
Date
04 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on April 24, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .